SCHEMBL3376961

SCHEMBL3376961

c1ccc(CN(Cc2ccccc2)[C]2CC2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.50
CYP2C19 P33261 1/20 0.48
ALDH1A1 P00352 2/20 0.48
CA2 P00918 1/20 0.45
AOC3 Q16853 1/20 0.44
MGLL Q99685 2/20 0.43
ADRA2A P08913 2/20 0.42
ADRA2C P18825 2/20 0.42
ADRA1A P35348 2/20 0.42
HRH1 P35367 2/20 0.42
SLC6A3 Q01959 2/20 0.42
KCNH2 Q12809 2/20 0.42
KMT2A Q03164 2/20 0.42
LMNA P02545 2/20 0.42
CHRM2 P08172 1/20 0.42
ADRA2B P18089 1/20 0.42
DRD1 P21728 1/20 0.42
SLC6A2 P23975 1/20 0.42
HTR2A P28223 1/20 0.42
SLC6A4 P31645 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3373133 0.91 TSHR (0.47) TSHRCYP2C19ALDH1A1CA2AOC3
SCHEMBL23064545 0.89 TSHR (0.45) TSHRCYP2C19ALDH1A1CA2AOC3
SCHEMBL3371521 0.87 TSHR (0.64) TSHRCYP2C19ALDH1A1AOC3MGLL
SCHEMBL3373915 0.83 TSHR (0.50) TSHRCYP2C19ALDH1A1AOC3MGLL
SCHEMBL3373523 0.80 NR1H2 (0.50) TSHRCYP2C19ALDH1A1ADRA2AADRA2C
SCHEMBL3375956 0.79 TSHR (0.60) TSHRCYP2C19ALDH1A1AOC3MGLL
SCHEMBL3375286 0.76 TSHR (0.56) TSHRALDH1A1CA2AOC3MGLL
SCHEMBL3376641 0.76 TSHR (0.47) TSHRCYP2C19ALDH1A1AOC3MGLL
SCHEMBL43183 0.74 TSHR (0.74) TSHRCYP2C19ALDH1A1AOC3ADRA2A
SCHEMBL2960872 0.74 CYP2C19 (0.78) TSHRCYP2C19ALDH1A1AOC3MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100324091-A1 Pyrazolone Derivative KOWA COMPANY, LTD. (JP) 2010-12-23 US disclosed
EP-2172458-A1 PYRAZOLONE DERIVATIVE Kowa Company, Ltd. (JP) 2010-04-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324091-A1 Pyrazolone Derivative SERPINE1, SERPINC1, TFPI TSHR 1622/4885CYP2C19 1060/4885ALDH1A1 517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.